Recurrence of gastric cancer in patients who are disease-free for more than 5 years after primary resection
Late recurrence of gastric cancer is rare and there are few data on recurrence in patients who are disease free for >5 years after gastrectomy. The aim of this study was to evaluate the predictors and status of tumor recurrence among these patients. Clinicopathologic characteristics, patterns of...
Saved in:
Published in | Surgery Vol. 159; no. 4; pp. 1090 - 1098 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.04.2016
|
Subjects | |
Online Access | Get full text |
ISSN | 0039-6060 1532-7361 1532-7361 |
DOI | 10.1016/j.surg.2015.11.002 |
Cover
Abstract | Late recurrence of gastric cancer is rare and there are few data on recurrence in patients who are disease free for >5 years after gastrectomy. The aim of this study was to evaluate the predictors and status of tumor recurrence among these patients.
Clinicopathologic characteristics, patterns of recurrence, and postrecurrence survival were analyzed in patients who were diagnosed as disease free at 5 years postoperatively and thereafter experienced recurrence. Independent factors associated with the late recurrence were analyzed.
Among 1,573 patients who underwent curative surgery from June 1992 to December 2006, 348 patients had recurrence. Of them, 7.6% (n = 25) suffered from late recurrence after 5 years after gastrectomy. Among patients who were diagnosed as disease free at 5 years after surgery, it accounted for 2.8% (25/902). Cases with late recurrence were characterized by more aggressive clinicopathologic features than those without recurrence. The median time to recurrence was 88.8 months (range, 64.8–238.0); of the 25 patients, 18 (72.0%) had recurrence within 8 years after surgery. The most common pattern was peritoneal recurrence (n = 19; 76.0%). The estimated median survival after recurrence was 9.4 months. On multivariate analysis, pT4 classification was the only independent risk factor for late recurrence. There were 185 patients with pT4 tumor who had no recurrence at 5 years after surgery; 19 (10.3%) had late recurrence.
pT4 tumor was the only important predictor of late recurrence. Whether extended follow-up for T4 tumors affects survival needs to be demonstrated in more large-scale studies. |
---|---|
AbstractList | Background Late recurrence of gastric cancer is rare and there are few data on recurrence in patients who are disease free for >5 years after gastrectomy. The aim of this study was to evaluate the predictors and status of tumor recurrence among these patients. Methods Clinicopathologic characteristics, patterns of recurrence, and postrecurrence survival were analyzed in patients who were diagnosed as disease free at 5 years postoperatively and thereafter experienced recurrence. Independent factors associated with the late recurrence were analyzed. Results Among 1,573 patients who underwent curative surgery from June 1992 to December 2006, 348 patients had recurrence. Of them, 7.6% ( n = 25) suffered from late recurrence after 5 years after gastrectomy. Among patients who were diagnosed as disease free at 5 years after surgery, it accounted for 2.8% (25/902). Cases with late recurrence were characterized by more aggressive clinicopathologic features than those without recurrence. The median time to recurrence was 88.8 months (range, 64.8–238.0); of the 25 patients, 18 (72.0%) had recurrence within 8 years after surgery. The most common pattern was peritoneal recurrence ( n = 19; 76.0%). The estimated median survival after recurrence was 9.4 months. On multivariate analysis, pT4 classification was the only independent risk factor for late recurrence. There were 185 patients with pT4 tumor who had no recurrence at 5 years after surgery; 19 (10.3%) had late recurrence. Conclusion pT4 tumor was the only important predictor of late recurrence. Whether extended follow-up for T4 tumors affects survival needs to be demonstrated in more large-scale studies. Late recurrence of gastric cancer is rare and there are few data on recurrence in patients who are disease free for >5 years after gastrectomy. The aim of this study was to evaluate the predictors and status of tumor recurrence among these patients. Clinicopathologic characteristics, patterns of recurrence, and postrecurrence survival were analyzed in patients who were diagnosed as disease free at 5 years postoperatively and thereafter experienced recurrence. Independent factors associated with the late recurrence were analyzed. Among 1,573 patients who underwent curative surgery from June 1992 to December 2006, 348 patients had recurrence. Of them, 7.6% (n = 25) suffered from late recurrence after 5 years after gastrectomy. Among patients who were diagnosed as disease free at 5 years after surgery, it accounted for 2.8% (25/902). Cases with late recurrence were characterized by more aggressive clinicopathologic features than those without recurrence. The median time to recurrence was 88.8 months (range, 64.8-238.0); of the 25 patients, 18 (72.0%) had recurrence within 8 years after surgery. The most common pattern was peritoneal recurrence (n = 19; 76.0%). The estimated median survival after recurrence was 9.4 months. On multivariate analysis, pT4 classification was the only independent risk factor for late recurrence. There were 185 patients with pT4 tumor who had no recurrence at 5 years after surgery; 19 (10.3%) had late recurrence. pT4 tumor was the only important predictor of late recurrence. Whether extended follow-up for T4 tumors affects survival needs to be demonstrated in more large-scale studies. Late recurrence of gastric cancer is rare and there are few data on recurrence in patients who are disease free for >5 years after gastrectomy. The aim of this study was to evaluate the predictors and status of tumor recurrence among these patients.BACKGROUNDLate recurrence of gastric cancer is rare and there are few data on recurrence in patients who are disease free for >5 years after gastrectomy. The aim of this study was to evaluate the predictors and status of tumor recurrence among these patients.Clinicopathologic characteristics, patterns of recurrence, and postrecurrence survival were analyzed in patients who were diagnosed as disease free at 5 years postoperatively and thereafter experienced recurrence. Independent factors associated with the late recurrence were analyzed.METHODSClinicopathologic characteristics, patterns of recurrence, and postrecurrence survival were analyzed in patients who were diagnosed as disease free at 5 years postoperatively and thereafter experienced recurrence. Independent factors associated with the late recurrence were analyzed.Among 1,573 patients who underwent curative surgery from June 1992 to December 2006, 348 patients had recurrence. Of them, 7.6% (n = 25) suffered from late recurrence after 5 years after gastrectomy. Among patients who were diagnosed as disease free at 5 years after surgery, it accounted for 2.8% (25/902). Cases with late recurrence were characterized by more aggressive clinicopathologic features than those without recurrence. The median time to recurrence was 88.8 months (range, 64.8-238.0); of the 25 patients, 18 (72.0%) had recurrence within 8 years after surgery. The most common pattern was peritoneal recurrence (n = 19; 76.0%). The estimated median survival after recurrence was 9.4 months. On multivariate analysis, pT4 classification was the only independent risk factor for late recurrence. There were 185 patients with pT4 tumor who had no recurrence at 5 years after surgery; 19 (10.3%) had late recurrence.RESULTSAmong 1,573 patients who underwent curative surgery from June 1992 to December 2006, 348 patients had recurrence. Of them, 7.6% (n = 25) suffered from late recurrence after 5 years after gastrectomy. Among patients who were diagnosed as disease free at 5 years after surgery, it accounted for 2.8% (25/902). Cases with late recurrence were characterized by more aggressive clinicopathologic features than those without recurrence. The median time to recurrence was 88.8 months (range, 64.8-238.0); of the 25 patients, 18 (72.0%) had recurrence within 8 years after surgery. The most common pattern was peritoneal recurrence (n = 19; 76.0%). The estimated median survival after recurrence was 9.4 months. On multivariate analysis, pT4 classification was the only independent risk factor for late recurrence. There were 185 patients with pT4 tumor who had no recurrence at 5 years after surgery; 19 (10.3%) had late recurrence.pT4 tumor was the only important predictor of late recurrence. Whether extended follow-up for T4 tumors affects survival needs to be demonstrated in more large-scale studies.CONCLUSIONpT4 tumor was the only important predictor of late recurrence. Whether extended follow-up for T4 tumors affects survival needs to be demonstrated in more large-scale studies. Late recurrence of gastric cancer is rare and there are few data on recurrence in patients who are disease free for >5 years after gastrectomy. The aim of this study was to evaluate the predictors and status of tumor recurrence among these patients. Clinicopathologic characteristics, patterns of recurrence, and postrecurrence survival were analyzed in patients who were diagnosed as disease free at 5 years postoperatively and thereafter experienced recurrence. Independent factors associated with the late recurrence were analyzed. Among 1,573 patients who underwent curative surgery from June 1992 to December 2006, 348 patients had recurrence. Of them, 7.6% (n = 25) suffered from late recurrence after 5 years after gastrectomy. Among patients who were diagnosed as disease free at 5 years after surgery, it accounted for 2.8% (25/902). Cases with late recurrence were characterized by more aggressive clinicopathologic features than those without recurrence. The median time to recurrence was 88.8 months (range, 64.8–238.0); of the 25 patients, 18 (72.0%) had recurrence within 8 years after surgery. The most common pattern was peritoneal recurrence (n = 19; 76.0%). The estimated median survival after recurrence was 9.4 months. On multivariate analysis, pT4 classification was the only independent risk factor for late recurrence. There were 185 patients with pT4 tumor who had no recurrence at 5 years after surgery; 19 (10.3%) had late recurrence. pT4 tumor was the only important predictor of late recurrence. Whether extended follow-up for T4 tumors affects survival needs to be demonstrated in more large-scale studies. |
Author | Lee, Ju-Hee Kwon, Sung Joon Jung, Min-Sung Kim, Min Gyu Ha, Tae Kyung Kim, Hyun-Il |
Author_xml | – sequence: 1 givenname: Ju-Hee surname: Lee fullname: Lee, Ju-Hee organization: Department of Surgery, Hanyang University Hospital, Seoul, Republic of Korea – sequence: 2 givenname: Hyun-Il surname: Kim fullname: Kim, Hyun-Il organization: Department of Surgery, Hanyang University Guri Hospital, Guri, Republic of Korea – sequence: 3 givenname: Min Gyu surname: Kim fullname: Kim, Min Gyu organization: Department of Surgery, Hanyang University Guri Hospital, Guri, Republic of Korea – sequence: 4 givenname: Tae Kyung surname: Ha fullname: Ha, Tae Kyung organization: Department of Surgery, Hanyang University Hospital, Seoul, Republic of Korea – sequence: 5 givenname: Min-Sung surname: Jung fullname: Jung, Min-Sung organization: Department of Surgery, Hanyang University Hospital, Seoul, Republic of Korea – sequence: 6 givenname: Sung Joon surname: Kwon fullname: Kwon, Sung Joon email: sjkwon@hanyang.ac.kr organization: Department of Surgery, Hanyang University Hospital, Seoul, Republic of Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26747230$$D View this record in MEDLINE/PubMed |
BookMark | eNqFks2KFDEUhYOMOD2jL-BCsnRTZW6SSlWJCMPgHwwI_oC7kE7dzKStrrRJSum38Vl8MlN062LAcRW4nO_ccM49IydTmJCQx8BqYKCebeo0x-uaM2hqgJoxfo-soBG8aoWCE7JiTPSVYoqdkrOUNoyxXkL3gJxy1cqWC7Yi4we0c4w4WaTB0WuTcvSWWlMGkfqJ7kz2OOVEf9wEaiLSwSc0CSsXEakLkW5DmeYbM9Hm1889mpiocbnQu-i3Ju5pxIQ2-zA9JPedGRM-Or7n5PPrV58u31ZX79-8u7y4qmzDu1w56AapOMNGtd3AHeccXY8dSNdIodYcG47QMmihl70Ua1BcKbnmXbfu-NCLc_L04LuL4duMKeutTxbH0UwY5qShbXknpJSiSJ8cpfN6i4M-_ln_SagI-EFgY0gpovsrAaaXGvRGLzXopQYNoEsNBepuQdZns0SQo_Hj3eiLA4oloO8eo07WL_UMPpYU9RD83fjLW7gd_eStGb_iHtMmzHEq0WvQiWumPy4nslwINOU4RPulGDz_t8H_tv8Gt0nLbw |
CitedBy_id | crossref_primary_10_4166_kjg_2019_73_3_141 crossref_primary_10_1007_s11605_023_05823_5 crossref_primary_10_1007_s10120_020_01147_4 crossref_primary_10_1007_s10120_022_01331_8 crossref_primary_10_1002_cam4_3899 crossref_primary_10_1016_j_gassur_2025_101958 crossref_primary_10_3892_ol_2019_10677 crossref_primary_10_1097_JS9_0000000000000731 crossref_primary_10_1007_s00464_021_08337_w crossref_primary_10_47429_lmo_2021_11_4_305 crossref_primary_10_1620_tjem_250_31 crossref_primary_10_1186_s40792_023_01660_5 crossref_primary_10_1007_s13691_021_00518_7 crossref_primary_10_1016_j_ejso_2022_01_018 crossref_primary_10_3389_fonc_2024_1326970 crossref_primary_10_1007_s12328_020_01143_2 crossref_primary_10_4143_crt_2019_210 crossref_primary_10_3389_fmolb_2021_744677 crossref_primary_10_1007_s12328_020_01315_0 crossref_primary_10_1007_s10120_024_01558_7 crossref_primary_10_1016_j_ejso_2022_04_018 crossref_primary_10_2169_internalmedicine_3847_19 crossref_primary_10_2147_CMAR_S264582 crossref_primary_10_1097_MD_0000000000029533 crossref_primary_10_1155_2022_4510000 crossref_primary_10_1001_jamasurg_2024_1754 crossref_primary_10_1001_jamasurg_2024_1753 crossref_primary_10_1007_s12029_021_00684_0 crossref_primary_10_1001_jamasurg_2024_4282 crossref_primary_10_1155_2016_2408645 crossref_primary_10_1186_s40792_019_0664_z crossref_primary_10_3389_fonc_2023_1158863 crossref_primary_10_1007_s00423_020_01996_8 crossref_primary_10_3389_fonc_2020_01469 crossref_primary_10_3389_fonc_2023_1283274 |
Cites_doi | 10.1093/annonc/mdp122 10.4251/wjgo.v4.i2.16 10.1038/nrc2256 10.1159/000227367 10.1200/JCO.2013.48.8585 10.1002/ssu.1046 10.1007/s101200050006 10.3322/caac.20107 10.1200/jco.2002.08.003 10.1007/BF01270600 10.1016/S0140-6736(10)61121-X 10.1016/S0140-6736(13)61719-5 10.1007/s10120-011-0042-4 10.1159/000320691 10.1046/j.1365-2036.16.s2.33.x 10.1038/bjc.2012.326 10.1016/j.cell.2013.10.029 10.1158/1078-0432.CCR-07-4354 10.1245/s10434-007-9479-4 10.1046/j.1365-2168.2000.01360.x 10.1016/j.ccr.2013.04.017 10.1038/sj.bjc.6605085 |
ContentType | Journal Article |
Copyright | 2016 Elsevier Inc. Elsevier Inc. Copyright © 2016 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2016 Elsevier Inc. – notice: Elsevier Inc. – notice: Copyright © 2016 Elsevier Inc. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.surg.2015.11.002 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1532-7361 |
EndPage | 1098 |
ExternalDocumentID | 26747230 10_1016_j_surg_2015_11_002 S003960601500937X 1_s2_0_S003960601500937X |
Genre | Evaluation Studies Journal Article |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .XZ .~1 0R~ 123 1B1 1CY 1P~ 1~. 1~5 354 4.4 457 4CK 4G. 53G 5RE 5VS 7-5 71M 8F7 8P~ AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABCQX ABFNM ABFRF ABLJU ABMAC ABMZM ABOCM ABWVN ABXDB ACDAQ ACGFO ACIEU ACRLP ACRPL ACVFH ACWUS ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV C45 CAG COF CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FD6 FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W J5H K-O KOM L7B M41 MO0 N4W N9A O-L O9- OAUVE OBH OHH OJ0 OV0 OVD OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SDF SDG SDP SEL SES SEW SJN SPCBC SSH SSZ T5K TEORI UDS UGJ UHS UQV UQZ UV1 VVN WH7 X7M YOC Z5R ZGI ZXP ZY1 ~G- AACTN AFKWA AJOXV AMFUW PKN RIG AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR ZA5 AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c528t-f18d4620e5678d2f222ef9e814f5436b2e52e17017194943b162664b288b82d93 |
IEDL.DBID | AIKHN |
ISSN | 0039-6060 1532-7361 |
IngestDate | Thu Sep 04 21:37:15 EDT 2025 Mon Jul 21 05:57:38 EDT 2025 Thu Apr 24 23:01:59 EDT 2025 Tue Jul 01 02:47:56 EDT 2025 Fri Feb 23 02:24:43 EST 2024 Tue Feb 25 20:06:36 EST 2025 Tue Aug 26 16:40:42 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 Copyright © 2016 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c528t-f18d4620e5678d2f222ef9e814f5436b2e52e17017194943b162664b288b82d93 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
PMID | 26747230 |
PQID | 1772834443 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1772834443 pubmed_primary_26747230 crossref_primary_10_1016_j_surg_2015_11_002 crossref_citationtrail_10_1016_j_surg_2015_11_002 elsevier_sciencedirect_doi_10_1016_j_surg_2015_11_002 elsevier_clinicalkeyesjournals_1_s2_0_S003960601500937X elsevier_clinicalkey_doi_10_1016_j_surg_2015_11_002 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-04-01 |
PublicationDateYYYYMMDD | 2016-04-01 |
PublicationDate_xml | – month: 04 year: 2016 text: 2016-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Surgery |
PublicationTitleAlternate | Surgery |
PublicationYear | 2016 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Eom, Yoon, Ryu, Lee, Cho, Lee (bib8) 2010; 27 Koga, Kaibara, Kishimoto, Nishidoi, Kimura, Okamoto (bib5) 1982; 356 Kienle, Koch (bib19) 2001; 20 Kim, Chang, Roh, Chae, Yang, Choi (bib2) 2003; 65 Kim, Lee, Kim, Yu, Yang (bib10) 1998; 1 Iwatsuki, Fukagawa, Mimori, Nakanishi, Ito, Ishii (bib25) 2009; 100 (bib7) 2011; 14 Fuchs, Tomasek, Yong, Dumitru, Passalacqua, Goswami (bib13) 2014; 383 Bang, Van Cutsem, Feyereislova, Chung, Shen, Sawaki (bib14) 2010; 376 Jackson, Cunningham, Oliveira (bib11) 2009; 20 Giancotti (bib18) 2013; 155 Yoo, Noh, Shin, Choi, Min (bib9) 2000; 87 Li, Qin, Xu, Guo, Xiong, Bai (bib15) 2013; 31 Baiocchi, D'Ugo, Coit, Hardwick, Kassab, Nashimoto (bib12) 2015 Jemal, Bray, Center, Ferlay, Ward, Forman (bib1) 2011; 61 Griniatsos, Michail, Dimitriou, Karavokyros (bib22) 2012; 4 Kang, Pantel (bib17) 2013; 23 Akiyoshi, Fukagawa, Ueo, Ishibashi, Takahashi, Fabbri (bib24) 2012; 107 Heiss, Simon, Beyer, Gruetzner, Tarabichi, Babic (bib23) 2002; 20 Maehara, Okuyama, Oshiro, Baba, Adachi, Sugimachi (bib6) 1994; 51 Park, Kwon, Lee (bib4) 2000; 59 Mimori, Fukagawa, Kosaka, Kita, Ishikawa, Etoh (bib21) 2008; 14 Moon, Jeung, Rha, Yoo, Roh, Noh (bib3) 2007; 14 Shin, Chung, Kim, Kim, Hur, Rhim (bib20) 2002; 16 Aguirre-Ghiso (bib16) 2007; 7 Jemal (10.1016/j.surg.2015.11.002_bib1) 2011; 61 Kienle (10.1016/j.surg.2015.11.002_bib19) 2001; 20 Iwatsuki (10.1016/j.surg.2015.11.002_bib25) 2009; 100 Kim (10.1016/j.surg.2015.11.002_bib2) 2003; 65 Griniatsos (10.1016/j.surg.2015.11.002_bib22) 2012; 4 Park (10.1016/j.surg.2015.11.002_bib4) 2000; 59 Li (10.1016/j.surg.2015.11.002_bib15) 2013; 31 Eom (10.1016/j.surg.2015.11.002_bib8) 2010; 27 Jackson (10.1016/j.surg.2015.11.002_bib11) 2009; 20 Heiss (10.1016/j.surg.2015.11.002_bib23) 2002; 20 Shin (10.1016/j.surg.2015.11.002_bib20) 2002; 16 Moon (10.1016/j.surg.2015.11.002_bib3) 2007; 14 Koga (10.1016/j.surg.2015.11.002_bib5) 1982; 356 Kim (10.1016/j.surg.2015.11.002_bib10) 1998; 1 Bang (10.1016/j.surg.2015.11.002_bib14) 2010; 376 Kang (10.1016/j.surg.2015.11.002_bib17) 2013; 23 Baiocchi (10.1016/j.surg.2015.11.002_bib12) 2015 Mimori (10.1016/j.surg.2015.11.002_bib21) 2008; 14 Maehara (10.1016/j.surg.2015.11.002_bib6) 1994; 51 Akiyoshi (10.1016/j.surg.2015.11.002_bib24) 2012; 107 Aguirre-Ghiso (10.1016/j.surg.2015.11.002_bib16) 2007; 7 Yoo (10.1016/j.surg.2015.11.002_bib9) 2000; 87 (10.1016/j.surg.2015.11.002_bib7) 2011; 14 Giancotti (10.1016/j.surg.2015.11.002_bib18) 2013; 155 Fuchs (10.1016/j.surg.2015.11.002_bib13) 2014; 383 |
References_xml | – volume: 87 start-page: 236 year: 2000 end-page: 242 ident: bib9 article-title: Recurrence following curative resection for gastric carcinoma publication-title: Br J Surg – volume: 356 start-page: 37 year: 1982 end-page: 42 ident: bib5 article-title: Comparison of 5- and 10-year survival rates in operated gastric cancer patients. Assessment of the 5-year survival rate as a valid indicator of postoperative curability publication-title: Langenbecks Arch Chir – volume: 20 start-page: 34 year: 2009 end-page: 36 ident: bib11 article-title: Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up publication-title: Ann Oncol – volume: 14 start-page: 113 year: 2011 end-page: 123 ident: bib7 article-title: Japanese gastric cancer treatment guidelines 2010 (ver. 3) publication-title: Gastric Cancer – volume: 31 start-page: 3219 year: 2013 end-page: 3225 ident: bib15 article-title: Apatinib for chemotherapy refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel arm, phase II trial publication-title: J Clin Oncol – volume: 376 start-page: 687 year: 2010 end-page: 697 ident: bib14 article-title: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial publication-title: Lancet – volume: 14 start-page: 2609 year: 2008 end-page: 2616 ident: bib21 article-title: Hematogenous metastasis in gastric cancer requires isolated tumor cells and expression of vascular endothelial growth factor receptor-1 publication-title: Clin Cancer Res – volume: 4 start-page: 16 year: 2012 end-page: 21 ident: bib22 article-title: Lymph node, peritoneal and bone marrow micrometastases in gastric cancer: Their clinical significance publication-title: World J Gastrointest Oncol – volume: 16 start-page: 137 year: 2002 end-page: 144 ident: bib20 article-title: Detection of cancer cells in peripheral blood of stomach cancer patients using RT-PCR amplification of tumour-specific mRNAs publication-title: Aliment Pharmacol Ther – volume: 51 start-page: 366 year: 1994 end-page: 371 ident: bib6 article-title: Analysis of 390 patients surviving 10 years or longer after curative resection for gastric cancer publication-title: Oncology – volume: 100 start-page: 1937 year: 2009 end-page: 1942 ident: bib25 article-title: Bone marrow and peripheral blood expression of ID1 in human gastric carcinoma patients is a bona fide indicator of lymph node and peritoneal metastasis publication-title: Br J Cancer – year: 2015 ident: bib12 article-title: Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference publication-title: Gastric Cancer – volume: 20 start-page: 2005 year: 2002 end-page: 2016 ident: bib23 article-title: Minimal residual disease in gastric cancer: evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow publication-title: J Clin Oncol – volume: 27 start-page: 481 year: 2010 end-page: 486 ident: bib8 article-title: Predictors of timing and patterns of recurrence after curative resection for gastric cancer publication-title: Dig Surg – volume: 14 start-page: 2730 year: 2007 end-page: 2737 ident: bib3 article-title: Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single Korean institute publication-title: Ann Surg Oncol – volume: 7 start-page: 834 year: 2007 end-page: 846 ident: bib16 article-title: Models, mechanisms and clinical evidence for cancer dormancy publication-title: Nat Rev Cancer – volume: 155 start-page: 750 year: 2013 end-page: 764 ident: bib18 article-title: Mechanisms governing metastatic dormancy and reactivation publication-title: Cell – volume: 107 start-page: 1345 year: 2012 end-page: 1353 ident: bib24 article-title: Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases publication-title: Br J Cancer – volume: 61 start-page: 69 year: 2011 end-page: 90 ident: bib1 article-title: Global cancer statistics publication-title: CA Cancer J Clin – volume: 1 start-page: 125 year: 1998 end-page: 133 ident: bib10 article-title: Clinicopathologic characteristics and prognostic factors in 10783 patients with gastric cancer publication-title: Gastric Cancer – volume: 23 start-page: 573 year: 2013 end-page: 581 ident: bib17 article-title: Tumor cell dissemination: emerging biological insights from animal models and cancer patients publication-title: Cancer Cell – volume: 65 start-page: 301 year: 2003 end-page: 308 ident: bib2 article-title: Factors influencing recurrence after curative resection for advanced gastric cancer publication-title: J Korean Surg Soc – volume: 20 start-page: 282 year: 2001 end-page: 293 ident: bib19 article-title: Minimal residual disease in gastrointestinal cancer publication-title: Semin Surg Oncol – volume: 59 start-page: 778 year: 2000 end-page: 785 ident: bib4 article-title: Clinicopathological characteristics of recurred gastric cancer patients after curative surgery publication-title: J Korean Surg Soc – volume: 383 start-page: 31 year: 2014 end-page: 39 ident: bib13 article-title: Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial publication-title: Lancet – volume: 20 start-page: 34 issue: Suppl 4 year: 2009 ident: 10.1016/j.surg.2015.11.002_bib11 article-title: Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up publication-title: Ann Oncol doi: 10.1093/annonc/mdp122 – year: 2015 ident: 10.1016/j.surg.2015.11.002_bib12 article-title: Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference publication-title: Gastric Cancer – volume: 4 start-page: 16 year: 2012 ident: 10.1016/j.surg.2015.11.002_bib22 article-title: Lymph node, peritoneal and bone marrow micrometastases in gastric cancer: Their clinical significance publication-title: World J Gastrointest Oncol doi: 10.4251/wjgo.v4.i2.16 – volume: 7 start-page: 834 year: 2007 ident: 10.1016/j.surg.2015.11.002_bib16 article-title: Models, mechanisms and clinical evidence for cancer dormancy publication-title: Nat Rev Cancer doi: 10.1038/nrc2256 – volume: 65 start-page: 301 year: 2003 ident: 10.1016/j.surg.2015.11.002_bib2 article-title: Factors influencing recurrence after curative resection for advanced gastric cancer publication-title: J Korean Surg Soc – volume: 51 start-page: 366 year: 1994 ident: 10.1016/j.surg.2015.11.002_bib6 article-title: Analysis of 390 patients surviving 10 years or longer after curative resection for gastric cancer publication-title: Oncology doi: 10.1159/000227367 – volume: 31 start-page: 3219 year: 2013 ident: 10.1016/j.surg.2015.11.002_bib15 article-title: Apatinib for chemotherapy refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel arm, phase II trial publication-title: J Clin Oncol doi: 10.1200/JCO.2013.48.8585 – volume: 20 start-page: 282 year: 2001 ident: 10.1016/j.surg.2015.11.002_bib19 article-title: Minimal residual disease in gastrointestinal cancer publication-title: Semin Surg Oncol doi: 10.1002/ssu.1046 – volume: 1 start-page: 125 year: 1998 ident: 10.1016/j.surg.2015.11.002_bib10 article-title: Clinicopathologic characteristics and prognostic factors in 10783 patients with gastric cancer publication-title: Gastric Cancer doi: 10.1007/s101200050006 – volume: 61 start-page: 69 year: 2011 ident: 10.1016/j.surg.2015.11.002_bib1 article-title: Global cancer statistics publication-title: CA Cancer J Clin doi: 10.3322/caac.20107 – volume: 20 start-page: 2005 year: 2002 ident: 10.1016/j.surg.2015.11.002_bib23 article-title: Minimal residual disease in gastric cancer: evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow publication-title: J Clin Oncol doi: 10.1200/jco.2002.08.003 – volume: 356 start-page: 37 year: 1982 ident: 10.1016/j.surg.2015.11.002_bib5 article-title: Comparison of 5- and 10-year survival rates in operated gastric cancer patients. Assessment of the 5-year survival rate as a valid indicator of postoperative curability publication-title: Langenbecks Arch Chir doi: 10.1007/BF01270600 – volume: 376 start-page: 687 year: 2010 ident: 10.1016/j.surg.2015.11.002_bib14 article-title: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(10)61121-X – volume: 383 start-page: 31 year: 2014 ident: 10.1016/j.surg.2015.11.002_bib13 article-title: Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial publication-title: Lancet doi: 10.1016/S0140-6736(13)61719-5 – volume: 14 start-page: 113 year: 2011 ident: 10.1016/j.surg.2015.11.002_bib7 article-title: Japanese gastric cancer treatment guidelines 2010 (ver. 3) publication-title: Gastric Cancer doi: 10.1007/s10120-011-0042-4 – volume: 27 start-page: 481 year: 2010 ident: 10.1016/j.surg.2015.11.002_bib8 article-title: Predictors of timing and patterns of recurrence after curative resection for gastric cancer publication-title: Dig Surg doi: 10.1159/000320691 – volume: 16 start-page: 137 issue: Suppl 2 year: 2002 ident: 10.1016/j.surg.2015.11.002_bib20 article-title: Detection of cancer cells in peripheral blood of stomach cancer patients using RT-PCR amplification of tumour-specific mRNAs publication-title: Aliment Pharmacol Ther doi: 10.1046/j.1365-2036.16.s2.33.x – volume: 107 start-page: 1345 year: 2012 ident: 10.1016/j.surg.2015.11.002_bib24 article-title: Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases publication-title: Br J Cancer doi: 10.1038/bjc.2012.326 – volume: 155 start-page: 750 year: 2013 ident: 10.1016/j.surg.2015.11.002_bib18 article-title: Mechanisms governing metastatic dormancy and reactivation publication-title: Cell doi: 10.1016/j.cell.2013.10.029 – volume: 14 start-page: 2609 year: 2008 ident: 10.1016/j.surg.2015.11.002_bib21 article-title: Hematogenous metastasis in gastric cancer requires isolated tumor cells and expression of vascular endothelial growth factor receptor-1 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-07-4354 – volume: 59 start-page: 778 year: 2000 ident: 10.1016/j.surg.2015.11.002_bib4 article-title: Clinicopathological characteristics of recurred gastric cancer patients after curative surgery publication-title: J Korean Surg Soc – volume: 14 start-page: 2730 year: 2007 ident: 10.1016/j.surg.2015.11.002_bib3 article-title: Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single Korean institute publication-title: Ann Surg Oncol doi: 10.1245/s10434-007-9479-4 – volume: 87 start-page: 236 year: 2000 ident: 10.1016/j.surg.2015.11.002_bib9 article-title: Recurrence following curative resection for gastric carcinoma publication-title: Br J Surg doi: 10.1046/j.1365-2168.2000.01360.x – volume: 23 start-page: 573 year: 2013 ident: 10.1016/j.surg.2015.11.002_bib17 article-title: Tumor cell dissemination: emerging biological insights from animal models and cancer patients publication-title: Cancer Cell doi: 10.1016/j.ccr.2013.04.017 – volume: 100 start-page: 1937 year: 2009 ident: 10.1016/j.surg.2015.11.002_bib25 article-title: Bone marrow and peripheral blood expression of ID1 in human gastric carcinoma patients is a bona fide indicator of lymph node and peritoneal metastasis publication-title: Br J Cancer doi: 10.1038/sj.bjc.6605085 |
SSID | ssj0009418 |
Score | 2.3407276 |
Snippet | Late recurrence of gastric cancer is rare and there are few data on recurrence in patients who are disease free for >5 years after gastrectomy. The aim of this... Background Late recurrence of gastric cancer is rare and there are few data on recurrence in patients who are disease free for >5 years after gastrectomy. The... Late recurrence of gastric cancer is rare and there are few data on recurrence in patients who are disease free for >5 years after gastrectomy. The aim of this... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1090 |
SubjectTerms | Adenocarcinoma - diagnosis Adenocarcinoma - etiology Adenocarcinoma - mortality Adenocarcinoma - surgery Adult Aged Disease-Free Survival Female Follow-Up Studies Gastrectomy Humans Male Middle Aged Multivariate Analysis Neoplasm Recurrence, Local - etiology Neoplasm Recurrence, Local - mortality Neoplasm Recurrence, Local - pathology Neoplasm Staging Retrospective Studies Risk Factors Stomach Neoplasms - diagnosis Stomach Neoplasms - etiology Stomach Neoplasms - mortality Stomach Neoplasms - surgery Surgery Survival Analysis Time Factors |
Title | Recurrence of gastric cancer in patients who are disease-free for more than 5 years after primary resection |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S003960601500937X https://www.clinicalkey.es/playcontent/1-s2.0-S003960601500937X https://dx.doi.org/10.1016/j.surg.2015.11.002 https://www.ncbi.nlm.nih.gov/pubmed/26747230 https://www.proquest.com/docview/1772834443 |
Volume | 159 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELba7YULAvG3pa2MxA2l3Ti2Yx-rimoB0ROV9mbFzrgsQtkq2RXiwrPwLDwZM4mzFWopEsdEGTkej-fHnvmGsde-sqWyUWcBypDJOpisUpQBIGSo0YGvvKF6548Xen4p3y_UYoedjbUwlFaZdP-g03ttnd6cJG6eXC-XVONbkPtNITuG5eVil-0JtPZmwvZO332YX9xg78p8UMiFzYgg1c4MaV7dpr2iDC91TGCe6XTlDvv0N_-zt0Pnj9jD5EDy0-EfH7MdaJ4wiiJ7oKUAfBX5VUXdOAIPtKQtXzY8wad2_NvnFa9a4OliJostAEfHlVPCLadzdK5-_fyO8t_xvn84vx7wKDjVKfVFEE_Z5fnbT2fzLPVRyIISZp3F3NRSixkotEy1iOgSQLRgchmVLLQXoAQQLnuZW2ll4XOMcrT0whhvRG2LZ2zSrBp4wbj3oiotzAKEKEEID1p7tINlJBz3YKcsH7nnQgIZp14XX92YTfbFEccdcRyjD4ccn7I3W5o0pXu_LsZFcWPxKKo7hxbgXqryLiro0o7tXO464WbullRNmdpS_iGY_xzx1SgxDncsXcNUDaw2OBIGNNTdRBZT9nwQpe28hcbwDqPC_f8c9SV7gE96SC06YJN1u4FD9JrW_ojtHv_Ij9Le-A0k1RZO |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELbK9gAXVMTfAgUjcUOhG8d24mNVtdrSdk-ttDcrdsZlK5Stkl2hvk2fhSdjJnEWoZYicU0ycjwez4898w1jn1xpcmWCTjzkPpGVL5JSUQaAkL5CB750BdU7n8309EJ-nav5FjsYamEorTLq_l6nd9o6PtmL3Ny7Xiyoxjcj95tCdgzL8_kjti2pqfWIbe8fn0xnv7F3Zdor5MwkRBBrZ_o0r3bdXFKGl_pCYJ7xdOUe-_Q3_7OzQ0c77Gl0IPl-_4_P2BbUzxlFkR3Qkge-DPyypG4cnnta0oYvah7hU1v-49uSlw3weDGThAaAo-PKKeGW0zk6Vz9vb1D-W971D-fXPR4FpzqlrgjiBbs4Ojw_mCaxj0LilShWSUiLSmoxAYWWqRIBXQIIBopUBiUz7QQoAYTLnqdGGpm5FKMcLZ0oCleIymQv2ahe1vCacedEmRuYePBBghAOtHZoB_NAOO7ejFk6cM_6CDJOvS6-2yGb7MoSxy1xHKMPixwfs88bmjilB7_OhkWxQ_EoqjuLFuBBqvw-Kmjjjm1talthJ_aOVI2Z2lD-IZj_HPHjIDEWdyxdw5Q1LNc4EgY01N1EZmP2qhelzbyFxvAOo8I3_znqB_Z4en52ak-PZydv2RN8o_s0o3dstGrWsIse1Mq9jzvkF7CVGDQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recurrence+of+gastric+cancer+in+patients+who+are+disease-free+for+more+than+5+years+after+primary+resection&rft.jtitle=Surgery&rft.au=Lee%2C+Ju-Hee&rft.au=Kim%2C+Hyun-Il&rft.au=Kim%2C+Min+Gyu&rft.au=Ha%2C+Tae+Kyung&rft.date=2016-04-01&rft.issn=1532-7361&rft.eissn=1532-7361&rft.volume=159&rft.issue=4&rft.spage=1090&rft_id=info:doi/10.1016%2Fj.surg.2015.11.002&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0039-6060&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0039-6060&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0039-6060&client=summon |